News
Gelteq
GELS · NASDAQ
$0.4303−$0.0046 (−1.06%)TodayMarket closed ·
Prev close $0.4349
Latest news
- News
12 Health Care Stocks Moving In Tuesday's After-Market Session
- NewsAvi Kapoor
Nasdaq Gains Over 200 Points; US Weekly Jobless Claims Edge Higher
- NewsAvi Kapoor
Why Snowflake Shares Are Trading Higher By Over 24%; Here Are 20 Stocks Moving Premarket
- News
12 Health Care Stocks Moving In Wednesday's After-Market Session
- News
12 Health Care Stocks Moving In Monday's After-Market Session
- News
12 Health Care Stocks Moving In Thursday's Intraday Session
- News
Gelteq Highlights Clinical And Commercial Progress, Advances Human And Veterinary Drug Programs Ahead Of Key FDA Milestones
- Press releaseGlobe Newswire
Gelteq Provides Corporate Update: Launching Veterinary and Human Clinical Trials, Pharmaceutical Pipeline Expanding Across Multiple Programs
- NewsKaustubh Bagalkote
What's Going On With Gelteq Stock Friday?
- News
12 Health Care Stocks Moving In Thursday's Intraday Session
- News
12 Health Care Stocks Moving In Wednesday's After-Market Session
- Press releaseGlobe Newswire
Gelteq Commences Veterinary Medicine Clinical Trial to Support an FDA Regulatory Pathway
- Press releaseACCESS Newswire
Healthy Extracts Q1 2026 Net Revenue Up 73% to Record $1.6 Million, Driving Positive EBITDA
- News
12 Health Care Stocks Moving In Wednesday's After-Market Session
- Press releaseGlobe Newswire
Gelteq Announces USD $3.5 Million Strategic Debt Financing to Accelerate Commercialization and Support Revenue Growth
- News
12 Health Care Stocks Moving In Thursday's Pre-Market Session
- Press releaseACCESS Newswire
Healthy Extracts Reports 2025 Net Revenue Up 45% to Record $4.5 Million
- Press releaseACCESS Newswire
Healthy Extracts Reports Preliminary 2025 Results, Net Revenue Expected Up 45% to Record $4.5 Million
- NewsRishabh Mishra
Stock Market Today: S&P 500, Dow Jones, Nasdaq 100 Futures Tumble Ahead Of SC Ruling On Trump's Tariffs— Wells Fargo, BP, WeRide In Focus (UPDATED)
- Press releaseACCESS Newswire
Healthy Extracts Reports Record Q3 2025, with Revenue up 23%
- Press releaseACCESS Newswire
Nutraceutical Technology Leader, Healthy Extracts, Invited to Present at the Trickle Research Microcap Conference on November 13, 2025
- News
Gelteq To Begin Preclinical Study Of Gel-Based Antihistamine Formulation In September 2025, Aiming For FDA Approval Via 505(b)(2) Regulatory Pathway
- Press releaseGlobe Newswire
Gelteq Announces Commencement of Preclinical Trial for Novel Gel-Based Antihistamine Formulation Targeting Allergy Market
- Press releaseACCESS Newswire
Healthy Extracts Builds Upon Record Q2 Results and Transformative Merger with Launch of New Revolutionary Hydration and Sugar Metabolism Gel-Packs
- News
12 Health Care Stocks Moving In Thursday's After-Market Session
- Press releaseACCESS Newswire
Healthy Extracts Reports Record Q2 2025 Net Revenue, Driving Positive EPS and EBITDA; Increases 2025 Net Revenue Guidance by 50%
- Press releaseACCESS Newswire
Healthy Extracts Expects Record Sales for Q2 2025, Driving Strong Positive Adj. EBITDA
- Press releaseGlobe Newswire
Gelteq Announces Agreement with IDT Australia to Secure Dedicated New Product Development and Manufacturing Facilities
- NewsAvi Kapoor
Why Toll Brothers Shares Are Trading Higher By Over 6%; Here Are 20 Stocks Moving Premarket
- NewsAvi Kapoor
Dow Jumps Over 400 Points; Verizon Earnings Top Views
- NewsAvi Kapoor
Why Calix Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket
- News
12 Health Care Stocks Moving In Monday's After-Market Session
- NewsAvi Kapoor
Why C3.ai Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.